angiogenesis inhibitors
Results Trial description recap V1

Aflibercept - Bevacizumab - Cediranib - Motesanib - Sorafenib - Vandetanib


Advanced breast cancer (metastatic)

second line therapy 2 trials

all type of patients 16 trials

first line therapy 8 trials

Lung cancer (metastatic)

all type of patients 30 trials

Renal-cell carcinoma (advanced)

all type of patients 3 trials

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons